Japanese pharmaceutical companies have lined up to develop a myriad of solutions to treat COVID-19 infections. One such company here…...
Please subscribe to read the full story.
Eisai
Anaeropharma Makes Progress With US Clinical Trials of New Anti-Cancer Drug
Anaeropharma Science Inc., a venture originating at Shinshu University, is set to advance its development of Bifidobacterium-based anti-cancer drug APS001F…....
Please subscribe to read the full story.
Eisai Eyes AI for Drug Discovery
Eisai Co. Ltd. (TYO:4523) is increasingly tapping into AI for its drug discovery research. This past June, the company began…...
Please subscribe to read the full story.
